Side-by-side comparison of AI visibility scores, market position, and capabilities
RTHM is a remote patient monitoring platform that uses wearable devices and AI to track chronic disease patients between clinical visits, enabling proactive care intervention. HQ: San Francisco.
RTHM is a remote patient monitoring (RPM) company providing technology and clinical services to help healthcare providers track patients with chronic conditions between office visits. The platform uses FDA-cleared wearable devices to continuously or periodically measure vital signs, symptoms, and disease-specific biomarkers, transmitting data to a clinical monitoring center where RTHM's care team reviews alerts and communicates with patients experiencing concerning trends before they escalate to emergency care.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.